RIPK2 and cervical squamous cell carcinoma: In the TCGA, we found that RIPK2 mutation status was associated with overall survival, progression-free survival, disease-free survival, and disease specificity of OV, PAAD, and PRAD, while no association was found in LUAD, HNSC, and CESC.